HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results o... by Francesca Carlino, Anna Diana, Anna Ventriglia, Antonio Piccolo, Carmela Mocerino, Ferdinando Riccardi, Domenico Bilancia, Francesco Giotta, Giulio Antoniol, Vincenzo Famiglietti, Salvatore Feliciano, Rodolfo Cangiano, Lorenzo Lobianco, Benedetta Pellegrino, Ferdinando De Vita, Fortunato Ciardiello, Michele Orditura

Get full text